Bluestar Genomics
About:
Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
Website: https://www.bluestargenomics.com
Twitter/X: bluestargenomic
Top Investors: Pathology Asia Holdings, Mattias Westman
Description:
Bluestar Genomics delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
Total Funding Amount:
$70M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)bluestargenomics.com
Founders:
Samuel Levy
Number of Employees:
11-50
Last Funding Date:
2021-05-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai